Evaluation of the Effect of Subcutaneous Injection of Piroxicam in Patients with Non Specific Shoulder Pai

Not Applicable

• Conditions: on Specific Shoulder Pain.; Pain in unspecified shoulder; M25.519

• Registration Number: IRCT20210423051050N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Patients over 18 years of age
Male or Female gender
Completing and signing the informed consent form
Patients with shoulder pain lasted more than 4 weeks and with a shoulder pain Visual Analog Scale (VAS) score of at least 4 in a recent month
Absence of any disease around the affected shoulder joint

Exclusion Criteria

Any pathology found on plain radiograph such as degenerative findings of the shoulder joint
Any clinical signs of effusion, inflammation, redness and warmth of the affected shoulder
Diabetes Mellitus
Uncontrolled Hypertension
Rheumatic and Collagen Vascular Diseases such as Lupus and Gout
Concomitant Radiculopathy (cervical radiculopathy), Myopathy, Nerve injuries and Neuropathies (including CTS)
Stroke
Any serious systemic and local infection
Brucellosis
BMI above 42
History of shoulder joint replacement on the affected side
History of shoulder trauma and fracture and severe deformities of the upper limbs
Bleeding tendency and bleeding disorders and/or use of anticoagulants
Inability to communicate and complete questionnaires (Mental and Psychological problems)
History of allergies and allergic reactions to the used drugs including piroxicam, corticosteroids and lidocaine
History of significant liver, kidney, brain and cardiopulmonary disorders
History of intraarticular or periarticular injections at the affected shoulder joint in the last 3 months
History of shoulder and upper limb physiotherapy (physical therapy) in the last 1 month
Pregnant and Lactating women
Patients with Cancer or Malignancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Shoulder pain. Timepoint: Before intervention; two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Visual Analogue Scale; Oxford Shoulder Score.

Secondary Outcome Measures

Name	Time	Method
Function of patient. Timepoint: Before intervention; two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Oxford Shoulder Score.